Mukka Proteins Ltd

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd has seen its quality grade downgraded from average to below average, reflecting a deterioration in key business fundamentals. The downgrade comes amid declining sales and earnings growth, elevated leverage ratios, and modest returns on capital, signalling caution for investors in this FMCG micro-cap stock.

Mukka Proteins Ltd has demonstrated a significant financial turnaround in the quarter ended December 2025, reversing a negative trend to deliver impressive revenue and profit growth. The company’s latest quarterly results reveal a marked improvement in key financial metrics, signalling renewed operational strength within the FMCG sector.

Mukka Proteins Ltd., a micro-cap player in India's FMCG seafood processing sector, delivered a spectacular topline performance in Q3 FY26 with net sales surging 167.19% quarter-on-quarter to ₹653.50 crores, marking the highest quarterly revenue in the company's history. However, the impressive sales momentum came at a cost, with consolidated net profit declining 9.56% year-on-year to ₹23.75 crores despite a sequential jump of 303.91%. Trading at ₹24.99 with a market capitalisation of ₹746.00 crores, the stock has corrected 28.50% over the past year, significantly underperforming the FMCG sector's 86.15% gain during the same period.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Mukka Proteins Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 0.47%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish outlook.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Mukka Proteins Ltd, a player in the FMCG sector, recorded a new 52-week and all-time low of Rs.20.74 on 21 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed both its sector and broader market indices over multiple time frames, reflecting persistent pressures on its financial and operational metrics.

Mukka Proteins Ltd has reached a new 52-week low of Rs.21.75, marking a significant decline in its share price as the stock continues to trade below all key moving averages amid subdued market sentiment and company-specific headwinds.

Mukka Proteins Ltd has reached a new all-time low of ₹21.75, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind both its sector and broader market indices, reflecting persistent difficulties across multiple financial metrics and investor sentiment.

Mukka Proteins Ltd’s shares declined to a fresh 52-week low of Rs.21.85 on 19 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and operational metrics.